Gut Microbiota-dependent Health Impacts of Haskap Berries
Montana State University · with Montana State Agricultural Experiment Station · NCT06546020
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 35–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- February 26, 2025
- Record last updated
- April 2, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Polyphenol-rich Haskap berries (Haskap) have untapped therapeutic potential to improve human health, and agricultural producers in northern U.S. states are poised to increase production if consumer demand increases. A critical knowledge gap is that little is known about the interactions between gut microbes and Haskap polyphenols to produce bioactive metabolites linked to downstream health impacts. Additionally, little is known about which Haskap varieties and harvest timing yield the greatest bioactive potential. This study aims to address these gaps by investigating the interaction of bioactive components in Haskap with gut microbiota and the resultant gut and serum metabolites, inflammation, and metabolic health, and then couple this with analysis of berries from different Haskap varieties and harvest times.
Being studied: Haskap berry smoothie; Placebo comparator
Conditions: Metabolic Disease; Inflammation; Microbial Colonization
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for Metabolically Healthy Group:
All of the following
- Waist circumference: men ≤ 40, women ≤ 35 inches
- Systolic blood pressure: ≤ 130 mmHg
- Diastolic blood pressure: ≤ 85 mmHg
- Fasting glucose: ≤ 100 mg·dl-1
- Fasting triglycerides: ≤ 150 mg·dl-1
- HDL: men > 40, women > 50 mg·dl-1
Inclusion Criteria for Metabolically Unhealthy Group:
Required
- Waist circumference: men ≥ 40, women ≥ 35 inches
AND ≥ 1 of the following:
- Systolic blood pressure: > 130 mmHg
- Diastolic blood pressure: > 85 mmHg
- Fasting glucose: > 100 mg·dl-1
- Fasting triglycerides: > 150 mg·dl-1
- HDL: men ≤ 40, women ≤ 50 mg·dl-1
Exclusion Criteria
- BMI \<18 or > 40 kg/m\^2
- potential allergy to Haskap or placebo ingredients
- use of anti-inflammatory, lipid lowering, glucose lowering, blood pressure, or any other medications that may interfere with study measures
- pregnant or lactating woman
- diagnosis with type 1 or type 2 diabetes or any other condition that may interfere with study measures
- smoke cigarettes
- have taken antibiotics in the past 90 days
- take supplements including pre/probiotics or "superfoods" within 30 days of starting the study
- are planning on starting a weight loss or exercise regiment change
- follow a specific diet such as low carbohydrate, vegan, and vegetarian
- consume over 5 servings of fruit/vegetables per day
- are unwilling to reduce caffeine intake to one 8 oz serving per day for the durations of the study
Recruiting US locations
Montana State University
Bozeman, MT 59717
Site contact: Mary P Miles, PhD · 406-994-6678 · mmiles@montana.edu
Study contacts (from the official record)
- Mary P Miles, PhD · 406-994-6678 · mmiles@montana.edu
- Zachary T Miller, PhD · (406) 961-3025 · zachariah.miller@montana.edu
Similar studies in Montana
All nutrition & metabolism studies in Montana →- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Kalispell, MT + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer
- Location
- Butte, MT + 4 other US sites
- Eligibility basics
- Ages 18+